JP2018179960A - Device for monitoring effective state of ketogenic meal - Google Patents

Device for monitoring effective state of ketogenic meal Download PDF

Info

Publication number
JP2018179960A
JP2018179960A JP2017162775A JP2017162775A JP2018179960A JP 2018179960 A JP2018179960 A JP 2018179960A JP 2017162775 A JP2017162775 A JP 2017162775A JP 2017162775 A JP2017162775 A JP 2017162775A JP 2018179960 A JP2018179960 A JP 2018179960A
Authority
JP
Japan
Prior art keywords
ketone
diet
animal
intake
ketone diet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017162775A
Other languages
Japanese (ja)
Other versions
JP6968624B2 (en
JP2018179960A5 (en
Inventor
欣也 芦田
Kinya Ashida
欣也 芦田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Co Ltd
Original Assignee
Meiji Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Co Ltd filed Critical Meiji Co Ltd
Priority to TW107111853A priority Critical patent/TWI816666B/en
Priority to US16/494,864 priority patent/US11249087B2/en
Priority to CN201880023394.9A priority patent/CN110506211A/en
Priority to PCT/JP2018/014673 priority patent/WO2018186481A1/en
Publication of JP2018179960A publication Critical patent/JP2018179960A/en
Publication of JP2018179960A5 publication Critical patent/JP2018179960A5/ja
Application granted granted Critical
Publication of JP6968624B2 publication Critical patent/JP6968624B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/64Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving ketones
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/497Physical analysis of biological material of gaseous biological material, e.g. breath
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/20Oxygen containing
    • Y10T436/200833Carbonyl, ether, aldehyde or ketone containing
    • Y10T436/202499Formaldehyde or acetone
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25875Gaseous sample or with change of physical state

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a device for measuring and monitoring an acetone amount in a gas discharged from the body of an animal to the outside, one time and/or a plurality of times over time, and a use method thereof.SOLUTION: A device 1 for monitoring effectiveness on a ketogenic meal includes: an ingestion information acquisition unit configured to acquire information on an ingestion amount of a ketogenic meal ingested in the body of an animal; an acetone concentration measurement unit 21a configured to measure acetone concentration which is an acetone amount in a gas discharged from the body of the animal to the outside; and a determination unit 32 configured to determine a metabolic state of the animal on the ketogenic meal, based on the information on the ingestion amount of the ketogenic meal acquired by the ingestion information acquisition unit and the information on the acetone amount measured by the acetone concentration measurement unit.SELECTED DRAWING: Figure 1

Description

本発明は、ケトン食の有効状態を管理するために用いられるモニタリング装置である。   The present invention is a monitoring device used to manage the effectiveness of the ketone diet.

これまでに、ケトン食、高脂肪食(特に糖質制限高脂肪食)が末期癌患者に対する治療方法の一つとなり得ることを想定し、日本人の末期肺癌患者に対するケトン食の有効性を検討し、ケトン食、例えば糖質制限高脂肪食を含む、がんを処置するための組成物またはその組合せにより、好ましくは、脂肪を120g以上とし、および/または炭水化物を1日30g以下に制限し、および/または一日摂取カロリーを20kcal/kg体重以上とし、および/または中鎖脂肪酸油(MCTオイル)等を組み合わせることで、予想外に顕著にがんを処置しQOLを改善することを見出している(特許文献1)。   Until now, assuming that ketone diet and high fat diet (especially carbohydrate limited high fat diet) can be one of the treatment methods for terminal cancer patients, we examine the effectiveness of ketone diet for Japanese terminal lung cancer patients Composition, or a combination thereof, for treating cancer, preferably containing at least 120 g of fat and / or at least 30 g of carbohydrate per day. And / or daily intake of 20 kcal / kg body weight or more, and / or combining medium-chain fatty acid oil (MCT oil) etc., unexpectedly found that treatment of cancer significantly improves QOL (Patent Document 1).

また、ケトン食が、脳機能改善や認知機能障害の予防・治療に有効であることが知られている(特許文献2)。さらに、ケトン食が、肥満症、循環器疾患、2型糖尿病、てんかん、ニキビ、癌、多嚢胞性卵巣症候群、神経障害、アルツハイマー病、パーキンソン病、頭部外傷に効果があることが知られている(非特許文献1)。   In addition, it is known that a ketone diet is effective for prevention and treatment of brain function improvement and cognitive dysfunction (Patent Document 2). Furthermore, it is known that ketone diet is effective for obesity, cardiovascular disease, type 2 diabetes, epilepsy, acne, cancer, polycystic ovary syndrome, neuropathy, Alzheimer's disease, Parkinson's disease, head trauma (Non-Patent Document 1).

これまでに、胃排出量の上昇を抑制し、かつ胃排出を遅延するための食品用の剤または医療用の剤を提供する目的で、鋭意検討する過程で、13C標識した各種アミノ酸を投与した動物の13CO2の呼気排泄量をモニターすることにより、アミノ酸の代謝量を、非侵襲的に呼気を検体として測定する方法を見出している(特許文献3)。   Until now, 13 C-labeled various amino acids were administered in the process of intensively studying for the purpose of providing an agent for food or a medicine for delaying gastric emptying and suppressing an increase in gastric emptying. By monitoring the exhaled amount of 13 CO 2 in animals, a method has been found to non-invasively measure the metabolic amount of amino acid as a sample of exhaled breath (Patent Document 3).

動物が摂取したケトン食は、動物の体内で代謝され、その一部はアセトンとなり動物の体内から、呼気や、皮膚や粘膜から体外に出される気体として、体外に排泄されることが、一般的に知られている。   It is general that the ketone diet ingested by the animal is metabolized in the body of the animal and part of it becomes acetone and excreted from the body of the animal as exhaled air or gas released from the skin or mucous membrane outside the body, It is known to.

気体中のアセトンの測定方法は、多機能呼気分析器(特許文献4)、呼気測定装置(特許文献5)などが知られている。   As a method of measuring acetone in gas, a multifunction breath analyzer (patent document 4), a breath measuring apparatus (patent document 5), and the like are known.

また、呼気アセトン量を用いて糖尿病指標値を推定するシステムが知られている(特許文献6)。   There is also known a system for estimating a diabetes index value using the amount of exhaled acetone (Patent Document 6).

国際公開第2017/038101号公報International Publication No. 2017/038101 国際公開第2016/013617号公報International Publication No. 2016/013617 特許第5938219号公報Patent No. 5938219 gazette 特許第5921562号公報Patent No. 5921562 特許第5139186号公報Patent No. 5139186 gazette 特開2015−102381号公報JP, 2015-102381, A

European Journal of ClinicalNu trition(2013)67,789−796European Journal of Clinical Nutrition (2013) 67, 789-796

これまでに、動物のケトン食の有効状態を管理するために、動物体内から体外に出される気体(呼気、皮膚や粘膜からの蒸散)中の代謝物量を測定するモニタリング装置は知られていなかった。ましてや、ケトン食を摂取している際のケトン食の有効状態を管理するためや、ケトン食の摂取が有効な疾患の病者及び/又は病者予備軍者を対象としてケトン食の有効状態を管理するためや、ケトン食の食事摂取の支援方法としてや、ケトン食をケトン体源として有効に代謝できる体調や体質か否かスクリーニングや判断する方法として、動物体内から体外に出される気体中のアセトン量を測定するモニタリング装置は知られていなかった。   Until now, there has been no known monitoring device for measuring the amount of metabolite in gas (exhaled breath, transpiration from skin or mucous membrane) discharged from the body of the animal to control the effective state of the ketone diet of the animal. . Furthermore, in order to control the effectiveness of the ketone diet when taking the ketone diet, or to the sick and / or spare patient of the disease for which the intake of the ketone diet is effective, the effectiveness of the ketone diet is As a method to support dietary intake of a ketone diet, or as a method of screening or judging whether a physical condition or constitution capable of effectively metabolizing a ketone diet as a ketone body source, or in a gas excreted from the body of an animal There is no known monitoring device for measuring the amount of acetone.

動物のケトン食の有効状態の管理において、非侵襲的に即時的や継続的などで、体外に出される気体中のアセトン量を測定して、動物のケトン食のケトン体源としての代謝状態をモニタリングできれば、ケトン食の有効状態を個別に管理できると考えられた。すなわち、このような装置の開発が課題であった。   In the management of the effective state of the ketone diet of the animal, the amount of acetone in the gas released outside the body is measured non-invasively, immediately and continuously, etc., and the metabolic state as the ketone body source of the ketone diet of the animal is determined. If monitoring was possible, it was thought that the effective state of the ketone diet could be managed individually. That is, the development of such a device has been a challenge.

本発明者は、鋭意努力し、動物の体内から体外に出される気体中のアセトン量を1回及び/又は複数回を経時的に測定し、モニタリングする装置とその使用方法を見出し、本発明を完成した。   The present inventor has made an effort to find an apparatus for measuring and monitoring the amount of acetone in a gas which is excreted from the body of an animal one or more times with time, and a method of using the same. completed.

本発明によれば、以下の発明が提供される。
[1] 動物体内から体外に出される気体中のアセトン量を、ケトン食の有効状態を管理するために1回及び/又は複数回測定する、モニタリング装置。
[2] [1]記載の動物がケトン食の摂取が有効な疾患の病者及び/又は病者予備軍者である、ケトン食の有効状態を管理するために1回及び/又は複数回測定する、モニタリング装置。
[3] [1]記載のケトン食の有効状態の管理を、ケトン食の摂取前後の動物体内での代謝に併せてケトン食の摂取を管理するために1回及び/又は複数回測定する、モニタリング装置。
[4] [1]記載のケトン食の有効状態の管理を、ケトン食の有効状態の維持・改善に対する対象者の適性をスクリーニングするために1回及び/又は複数回測定する、モニタリング装置。
According to the present invention, the following inventions are provided.
[1] A monitoring device which measures the amount of acetone in a gas which is excreted from the body of an animal once or / or several times in order to control the effective state of a ketone diet.
[2] [1] The animal according to [1] is a sick person and / or a sick person who is a patient with a disease for which the intake of the ketone diet is effective, measurement once and / or multiple times to control the effectiveness of the ketone diet Monitoring device.
[3] The management of the effective state of the ketone diet described in [1] is measured once and / or multiple times to control the intake of the ketone diet in conjunction with the metabolism in the animal body before and after the intake of the ketone diet, Monitoring device.
[4] A monitoring device which measures the management of the effective state of the ketone diet as described in [1] once and / or multiple times in order to screen the subject's suitability for maintenance / improvement of the effective state of the ketone diet.

また、本願発明のケトン食モニタリング装置は、ケトン食の有効性をモニタリングするケトン食モニタリング装置であって、動物の体内に摂取されるケトン食の摂取量の情報を取得する摂取情報取得部と、前記動物の体内から体外に出される気体中のアセトン量であるアセトン濃度を測定するアセトン濃度測定部と、前記摂取情報取得部により取得した前記ケトン食の摂取量の情報と、前記アセトン濃度測定部により測定された前記アセトン濃度の情報とに基づいて前記動物による前記ケトン食の代謝状態を判定する判定部と、を有することを特徴とする。   Further, the ketone diet monitoring device of the present invention is a ketone diet monitoring device that monitors the effectiveness of the ketone diet, and an intake information acquisition unit that acquires information on the intake amount of the ketone diet ingested into the body of the animal; An acetone concentration measurement unit that measures an acetone concentration, which is the amount of acetone in the gas taken out of the body of the animal from the body, information on the intake amount of the ketone food acquired by the intake information acquisition unit, and the acetone concentration measurement unit A determination unit that determines the metabolic state of the ketone diet by the animal based on the information on the acetone concentration measured by

前記判定部は、前記ケトン食の摂取前後での前記アセトン濃度の増減に基づいて前記判定を行うことが好ましい。そして、前記判定部は、前記ケトン食の摂取前と比較して前記アセトン濃度が増加傾向を示す場合に、前記動物が前記ケトン食をケトン体源として代謝している状態、あるいは、前記動物が前記ケトン食をケトン体源として代謝可能な体調又は体質であると判定することが好ましい。   It is preferable that the determination unit performs the determination based on increase and decrease of the acetone concentration before and after intake of the ketone diet. And the said determination part is a state which the said animal metabolises the said ketone diet as a ketone body source, or when the said acetone concentration shows a tendency to increase compared with before intake of the said ketone diet, or the said animal It is preferable to determine that the ketone diet is a physical condition or constitution metabolizable as a ketone body source.

本発明によれば、動物の体内から体外に出される気体中の代謝物量を1回及び/又は複数回を経時的に測定し、モニタリングする装置、及びその使用方法が提供できる。そして、本発明のモニタリングする装置、及びその使用方法を提供できることにより、ケトン食を摂取している際のケトン食の有効状態の管理や、ケトン食の摂取が有効な疾患の病者及び/又は病者予備軍者を対象としたケトン食の有効状態の管理や、ケトン食の食事摂取の支援方法としてケトン食をケトン体源として有効に代謝できる体調や体質か否かのスクリーニングや判断が可能となる。   According to the present invention, it is possible to provide an apparatus for measuring and monitoring the amount of metabolite in a gas which is excreted from the body of an animal one time and / or several times, and a method of using the same. And, by being able to provide the monitoring apparatus of the present invention and the method of using the same, the management of the effective state of the ketone diet when taking the ketone diet, and the sick and / or the person whose disease is effective in taking the ketone diet. It is possible to screen and judge the physical condition and constitution that can effectively metabolize ketone diet as a ketone body source as a management method of the effective condition of ketone diet for the patient's spare armed forces, and as a support method of diet intake of ketone diet It becomes.

本発明によれば、ケトン食を摂取させた場合に、動物の体内から体外に出される気体中のアセトン量を1回及び/又は複数回を経時的に測定し、モニタリングする装置とその使用方法を提供できる。   According to the present invention, an apparatus and method for measuring and monitoring the amount of acetone in a gas which is taken out from the body of an animal one time and / or a plurality of times when a ketone diet is ingested and the use thereof Can provide

本発明によれば、ケトン食の摂取が有効な疾患の病者及び/又は病者予備軍者の体内から体外に出される気体中のアセトン量を1回及び/又は複数回を経時的に測定し、モニタリングする装置とその使用方法を提供できる。   According to the present invention, the amount of acetone in the gas which is taken out of the body from the body of a patient and / or a preparatory person of a disease for whom the intake of a ketone diet is effective is measured once and / or several times over time Provide monitoring and monitoring devices and methods for their use.

本発明のモニタリング装置によれば、動物体内から体外に出される気体(呼気、皮膚や粘膜からの蒸散)中の代謝物量を測定して動物のケトン食の有効状態を管理できる。   According to the monitoring device of the present invention, it is possible to manage the effective state of the ketone diet of the animal by measuring the amount of metabolite in the gas (exhaled breath, transpiration from the skin or mucous membrane) which is discharged from the animal body.

本発明のモニタリング装置によれば、ケトン食を摂取させた場合に、動物体内から体外に出される気体(呼気、皮膚や粘膜からの蒸散)中の代謝物量を測定して動物のケトン食の有効状態を管理できる。   According to the monitoring device of the present invention, when the ketone diet is ingested, the amount of metabolite in the gas (exhaled breath, transpiration from the skin or mucous membrane) which is excreted from the animal body is measured to make the ketone diet effective. Can manage the state.

本発明のモニタリング装置によれば、ケトン食の摂取が有効な疾患の病者及び/又は病者予備軍者を対象として、動物体内から体外に出される気体中のアセトン量を測定してそのケトン体源としての代謝率を勘案し、食事中の糖質と脂質のバランスを調整するなどの食事の管理ができる。ケトン食は、その嗜好性から、好みにより、多量に摂取することが困難な場合がある。   According to the monitoring apparatus of the present invention, it is possible to measure the amount of acetone in the gas which is taken out from the body of the animal from the animal body for the sick and / or spare sick for the disease for which the intake of the ketone diet is effective. The diet can be managed by adjusting the balance of carbohydrates and lipids in the diet in consideration of the metabolic rate as a body source. Due to their palatability, it is sometimes difficult to ingest a large amount of ketone diet.

本発明により、モニタリングしながら摂取を調整することで、必要十分量としての適度な量のみを摂食とすることができ、好みでないケトン食を過剰に摂取することを避けることができる。本発明により、モニタリングしながらケトン食の摂取を調整することで(体調の維持や改善に有効なケトン食の摂食量が明確になることで)、摂食する動物(特にヒト)が、意識的或いは無意識的に摂食できる効果も併せ持つ。   According to the present invention, by adjusting intake while monitoring, it is possible to feed only a proper amount as a necessary and sufficient amount, and it is possible to avoid excessive intake of a non-preferred ketone diet. According to the present invention, by adjusting the intake of the ketone diet while monitoring (by the fact that the amount of intake of the ketone diet effective for maintenance and improvement of physical condition is clarified), the animals (especially humans) who eat it are conscious Or it also has the effect of being able to eat unconsciously.

本発明のモニタリング装置によれば、動物体内から体外に出される気体中のアセトン量を測定して、ケトン食をケトン体源として有効に代謝できる体調や体質か否かのスクリーニングや判断ができる。   According to the monitoring device of the present invention, it is possible to measure the amount of acetone in the gas which is discharged from the animal body to the outside, and to screen or judge whether it is a physical condition or constitution capable of effectively metabolizing ketone diet as a ketone body source.

本発明に関連する更なる特徴は、本明細書の記述、添付図面から明らかになるものである。また、上記した以外の、課題、構成及び効果は、以下の実施形態の説明により明らかにされる。   Further features related to the present invention will become apparent from the description of the present specification and the accompanying drawings. Further, problems, configurations and effects other than those described above will be clarified by the description of the following embodiments.

本実施形態に係わるモニタリング装置の例を示す機能ブロック図。FIG. 2 is a functional block diagram showing an example of a monitoring device according to the present embodiment. 本実施形態に係わるモニタリング装置の例を示す機能ブロック図。FIG. 2 is a functional block diagram showing an example of a monitoring device according to the present embodiment. 本実施形態に係わるモニタリング装置の全体構成を示す機能ブロック図。BRIEF DESCRIPTION OF THE DRAWINGS The functional block diagram which shows the whole structure of the monitoring apparatus concerning this embodiment. 本実施形態に係わるモニタリング装置の構成を示す機能ブロック図。FIG. 2 is a functional block diagram showing a configuration of a monitoring device according to the present embodiment.

以下、本発明の好ましい実施形態について詳細に説明するが、本発明は以下に述べる個々の形態には限定されない。   Hereinafter, preferred embodiments of the present invention will be described in detail, but the present invention is not limited to the individual forms described below.

本発明において使用され得る対象の動物としては、任意の哺乳動物を挙げることができ、例えば、マウス、ラット、ハムスター、モルモット等のげっ歯類、ウサギ等のウサギ目、ブタ、ウシ、ヤギ、ウマ、ヒツジ等の有蹄目、イヌ、ネコ等のネコ目、ヒト、サル、アカゲザル、カニクイザル、マーモセット、オランウータン、チンパンジーなどの霊長類等を挙げることが出来る。哺乳動物は、好ましくはげっ歯類(マウス等)または霊長類(ヒト等)であり、より好ましくは霊長類、さらに好ましくはヒトである。   Examples of target animals that can be used in the present invention include any mammals, and examples include rodents such as mice, rats, hamsters and guinea pigs, lagomorphs such as rabbits, pigs, cows, goats and horses. And ovines such as sheep, felines such as dogs and cats, and primates such as humans, monkeys, rhesus monkeys, cynomolgus monkeys, marmosets, orangutans and chimpanzees. The mammal is preferably a rodent (such as mouse) or a primate (such as human), more preferably a primate, and even more preferably a human.

本発明において、ケトン食の有効状態とは、動物が体外からケトン食を摂取し、ケトン食を、動物の生体の維持や動物の生活活動に有効に利用している状態である。ケトン食の有効状態は、ケトン食をケトン体源として有効に代謝している状態から判断でき、例えば、動物の体内から体外に出される気体(呼気、皮膚や粘膜からの蒸散)中のアセトン量の状態で判断できる。動物の体内から体外に出される気体(呼気、皮膚や粘膜からの蒸散)中のアセトン量は、絶対量及び/又は相対量で管理されても良い。また、動物の体内から体外に出される気体(呼気、皮膚や粘膜からの蒸散)中のアセトン量は、動物の個体差があるため、同一個体でケトン食を摂取しない時期と摂取している時期や、ケトン食の摂取前や摂取後での、アセトン量の上昇、低減及び/又は増加等で判断すればよく、ケトン食の摂取前と比較して、一定の増加傾向が示されれば、それらの効果があるものと判断できる。例えば、当該増加傾向は統計学的に有意な差が示されることがより好ましい。   In the present invention, the effective state of the ketone diet means that the animal ingests the ketone diet from outside the body, and the ketone diet is effectively used for the maintenance of the living body of the animal and the life activity of the animal. The effective state of the ketone diet can be determined from the state in which the ketone diet is effectively metabolized as a ketone body source, for example, the amount of acetone in the gas (breath, transpiration from skin and mucous membranes) released from the body of the animal It can be judged in the state of The amount of acetone in the gas (exhaled breath, transpiration from the skin or mucous membranes) discharged from the body of the animal may be managed in absolute and / or relative amounts. In addition, the amount of acetone in the gas (exhaled breath, transpiration from the skin and mucous membranes) released from the body of the animal from the body is different between animals, so the same individual does not take the ketone diet and the time it is ingested. Or, it may be judged by the increase, decrease and / or increase of the amount of acetone before and after the intake of the ketone food, and if a certain increase tendency is shown as compared to before the intake of the ketone food, It can be judged that those effects are present. For example, it is more preferable that the increase tendency is statistically significant.

また、同一個体でケトン食を摂取しない時期と摂取している時期や、ケトン食の摂取前や摂取後での、アセトン量の差が一定の状態であったとしても、その効果が維持されており、好ましいと判断できる。   Moreover, even if the difference between the amounts of acetone before and after the intake of the ketone diet is constant, the effect is maintained even when the same individual does not take the ketone diet and when the ketone diet is consumed. It can be judged to be preferable.

本発明において、ケトン食の有効状態の管理とは、ケトン食がケトン体源として有効に代謝されている状態を把握して、目的とした範囲内での動物の体調の維持及び/又は改善をはかることである。   In the present invention, the management of the effective state of the ketone diet means grasping the state where the ketone diet is effectively metabolized as a ketone body source, and maintaining and / or improving the physical condition of the animal within the intended range. It is hard to do.

本発明において、ケトン食とは、動物の生体内でケトン体を産生し得る食事又は食品である。例えば、高脂肪食、中鎖脂肪酸食、ケトン体エステル、ケト原性アミノ酸を配合した食品である。また、本発明において、これらのケトン食をケトン体源食と称することがある。   In the present invention, the ketone diet is a diet or food that can produce a ketone body in vivo in an animal. For example, it is a food blended with a high-fat diet, a medium-chain fatty acid diet, a ketone ester, and a ketogenic amino acid. Also, in the present invention, these ketones are sometimes referred to as ketone body source food.

特に、がんを処置するためのケトン食またはその組合せは、例えば、ケトン食、特に高脂肪食(例えばいわゆる「糖質制限高脂肪食」)があげられる。上記、がん患者の体内から体外に出される気体は、例えば、呼気、皮膚や粘膜から体外に出される気体があげられる。   In particular, ketone diets or combinations thereof for treating cancer include, for example, ketone diets, particularly high fat diets (eg, so-called "carbohydrate limited high fat diets"). Examples of the gas that is released from the body of the cancer patient as described above include exhaled air and gases that are released from the skin and mucous membranes.

本発明において、ケトン食の有効状態を管理される動物は、ケトン食の摂取が有効な疾患の病者及び/又は病者予備軍者などであってよく、本発明における、ケトン食の摂取が有効な疾患は、肥満症、循環器疾患、2型糖尿病、てんかん、ニキビ、癌、多嚢胞性卵巣症候群、神経障害、アルツハイマー病、パーキンソン病、頭部外傷があげられる。   In the present invention, the animal whose effective state of ketone diet is controlled may be a sick person and / or a sick person who has a disease for which the intake of ketone diet is effective, and the intake of ketone food according to the present invention is Effective diseases include obesity, cardiovascular disease, type 2 diabetes, epilepsy, acne, cancer, polycystic ovary syndrome, neuropathy, Alzheimer's disease, Parkinson's disease and head trauma.

本発明において、ケトン食の摂取が有効な疾患の病者とは、上記疾患と診断されたものであり、病者予備軍者とは、上記疾患の可能性が診断されていたり、上記疾患の傾向及び/又は予兆があるものをいう。また、病者予備軍者とは、さらに、遺伝的に上記疾患に罹患する可能性が高いもの及び/又は自らの意志で上記疾患の予防のためにケトン食の摂取を希望するものを含む。   In the present invention, a patient suffering from a disease effective to take a ketone diet is one diagnosed with the above disease, and one or more persons with a diseased person have been diagnosed from the possibility of the above disease, or Refers to things that have trends and / or signs. In addition, the patient reserve further includes those who are genetically likely to be affected by the disease and / or those who desire to take the ketone diet for the prevention of the disease at their own will.

本発明において、ケトン食の摂取の前後でケトン食の摂取の量を決めるために本発明装置によってモニタリングされても良い。また、上記、ケトン食の有効状態を管理される動物が、ケトン食を摂取した後に、ケトン食をケトン体源として有効に代謝できる体調や体質か否かスクリーニングや判断するために、本発明装置によってモニタリングされても良い。   In the present invention, the apparatus may be monitored by the present invention to determine the amount of intake of the ketone diet before and after the intake of the ketone diet. In addition, the device according to the present invention is used to screen or judge whether or not the above-mentioned animal whose controlled condition of the ketone diet can effectively metabolize the ketone diet as a ketone body source after taking the ketone diet. It may be monitored by

図1及び図2は、本実施形態に係わるモニタリング装置の例を示す機能ブロック図である。   FIG.1 and FIG.2 is a functional block diagram which shows the example of the monitoring apparatus concerning this embodiment.

モニタリング装置1は、例えば図1に示すように、モニタリング端末装置2とモニタリング管理装置3を備えている。モニタリング端末装置2とモニタリング管理装置3は、通信回路4を介して接続されており、互いに情報の送受信を行うことができる。モニタリング端末装置2は、アセトン濃度測定部21aを含む測定部21と、判定表示部22aを含む表示部22を有している。そして、モニタリング管理装置3は、データ取得部31と判定部32を有している。   For example, as shown in FIG. 1, the monitoring device 1 includes a monitoring terminal device 2 and a monitoring management device 3. The monitoring terminal device 2 and the monitoring management device 3 are connected via the communication circuit 4 and can mutually transmit and receive information. The monitoring terminal device 2 includes a measurement unit 21 including an acetone concentration measurement unit 21 a and a display unit 22 including a determination display unit 22 a. The monitoring management device 3 includes a data acquisition unit 31 and a determination unit 32.

モニタリング端末装置2のアセトン濃度測定部21aは、動物の体内から体外に出される気体中のアセトン量であるアセトン濃度を測定する。そして、判定表示部22aは、モニタリング管理装置3の判定部32による判定結果を表示する。   The acetone concentration measurement unit 21a of the monitoring terminal device 2 measures the acetone concentration which is the amount of acetone in the gas taken out of the body of the animal. Then, the determination display unit 22 a displays the determination result by the determination unit 32 of the monitoring management device 3.

モニタリング管理装置3のデータ取得部31は、ケトン食の摂取情報と、アセトン濃度の情報と、ケトン食を摂取する動物の個体情報を取得する。ケトン食の摂取情報には、動物の体内に摂取されるケトン食の摂取量の情報が含まれており、さらに、ケトン食の摂取時刻、摂取期間、種類等の情報の少なくとも一つが含まれていてもよい。そして、動物の個体情報には、動物の種類、年齢、性別、体格、体調、体質、病名等の情報の少なくとも一つが含まれていてもよい。   The data acquisition unit 31 of the monitoring management device 3 acquires the intake information of the ketone diet, the information of the acetone concentration, and the individual information of the animal that ingests the ketone diet. The intake information on the ketone diet includes information on the intake amount of the ketone diet ingested into the body of the animal, and further includes at least one of information on the intake time, intake period, type, etc. of the ketone diet. May be The individual information of the animal may include at least one of information such as the type of animal, age, sex, physical constitution, physical condition, constitution, disease name and the like.

ケトン食の摂取情報と動物の個体情報は、モニタリング端末装置2やモニタリング管理装置3に設けられている不図示の入力手段からデータ取得部31に入力される。すなわち、データ取得部31は、摂取情報取得部としてケトン食の摂取情報を取得する。そして、アセトン濃度の情報は、アセトン濃度測定部21aから取得する。   The intake information of the ketone diet and the individual information of the animal are input to the data acquisition unit 31 from input means (not shown) provided in the monitoring terminal device 2 or the monitoring management device 3. That is, the data acquisition unit 31 acquires the intake information of the ketone food as the intake information acquisition unit. Then, information on the acetone concentration is obtained from the acetone concentration measurement unit 21a.

判定部32は、ケトン食の摂取情報とアセトン濃度の情報とに基づいて動物によるケトン食の代謝状態を判定する。判定部32は、ケトン食がケトン体源として有効に代謝されているか否か、すなわち、動物の体内でケトン体が産生されているか否かを判定する。判定部32は、例えばケトン食の摂取前後でのアセトン濃度の増減に基づいて代謝状態の判定を行う。判定部32は、ケトン食の摂取前と比較して摂取後のアセトン濃度が増加傾向を示す場合に、その動物がケトン食をケトン体源として有効に代謝している状態、あるいは、動物がケトン食をケトン体源として有効に代謝可能な体調又は体質であると判定する。   The determination unit 32 determines the metabolic state of the ketone diet by the animal based on the intake information on the ketone diet and the information on the acetone concentration. The determination unit 32 determines whether the ketone diet is effectively metabolized as a ketone body source, that is, whether or not a ketone body is produced in the animal. The determination unit 32 determines the metabolic state, for example, based on the increase and decrease of the acetone concentration before and after intake of the ketone diet. When the concentration of acetone after intake shows a tendency to increase as compared with that before intake of the ketone diet, the determination unit 32 indicates that the animal is effectively metabolizing the ketone diet as a ketone body source, or the animal is a ketone The food is determined to be a physical condition or constitution that can be effectively metabolized as a ketone body source.

判定部32は、例えば、動物の体重(Kg)あたりのケトン食摂取量(g)と、ケトン食の摂取前後のアセトン濃度の差とに基づいて、ケトン食の摂取によるアセトン濃度の増加率を算出する。そして、予め設定されている基準値と比較して、基準値を超えている場合にはアセトン濃度が増加傾向を示しているので、ケトン食をケトン体源として有効に代謝している状態、あるいは、動物がケトン食をケトン体源として有効に代謝可能な体調又は体質であると判断する。一方、基準値以下の場合にはアセトン濃度が増加傾向を示していないので、ケトン食をケトン体源として有効に代謝していない状態、あるいは、動物がケトン食をケトン体源として有効に代謝可能な体調又は体質でないと判断する。また、例えば、アセトン濃度の増加率が、段階的に範囲が設定されている複数の代謝レベル(レベル1〜5)のいずれに属するか否かを判定してもよい。   The determination unit 32 determines, for example, the rate of increase of the acetone concentration due to the intake of the ketone food based on the ketone food intake (g) per body weight (Kg) of the animal and the difference between the acetone concentrations before and after the intake of the ketone food. calculate. And since the acetone concentration tends to increase when it exceeds the standard value compared with the standard value set in advance, the state in which the ketone diet is effectively metabolized as a ketone body source, or The animal is judged to be in a physical condition or constitution capable of effectively metabolizing a ketone diet as a ketone body source. On the other hand, since the acetone concentration does not show a tendency to increase when below the standard value, a state in which ketone diet is not effectively metabolized as a ketone body source, or an animal can effectively metabolize ketone diet as a ketone body source Judged as having no physical condition or constitution. In addition, for example, it may be determined which of a plurality of metabolic levels (levels 1 to 5) in which the increase rate of acetone concentration is set stepwise.

基準値や代謝レベルの範囲を、動物の個体情報に基づいて補正してもよい。例えば、大人の男性等の体格が大きい動物の場合は基準値を高くする方向に補正し、大人の女性や子供等の体格が小さい動物の場合は基準値を低くする方向に補正してもよい。   Ranges of reference values and metabolic levels may be corrected based on individual information of animals. For example, in the case of an animal with a large physical size such as an adult male, correction may be made to increase the reference value, and in the case of an animal with a small physical size such as an adult woman or a child, correction may be made to decrease the reference value. .

判定部32の判定結果は、モニタリング端末装置2の判定表示部22aに表示される。したがって、判定表示部22aを見ることによって、その動物に対してケトン食の摂取が有効であるか否かを認識することができる。補正は、行政機関などが発表する統計情報、論文発表・学会発表などの公開情報、独自で蓄積したデータに基づく非公開情報などを基に行うことができる。当該補正は、人為的に行うこともでき、AI(人工知能)などの機能も利用できる。   The determination result of the determination unit 32 is displayed on the determination display unit 22 a of the monitoring terminal device 2. Therefore, by looking at the judgment display portion 22a, it can be recognized whether or not the intake of the ketone diet is effective for the animal. The correction can be performed based on statistical information published by the administrative organization, public information such as dissertation and academic conference presentation, and private information based on data accumulated uniquely. The correction can be made artificially, and functions such as AI (Artificial Intelligence) can also be used.

上記した構成を有するモニタリング装置1によれば、判定結果に基づいてケトン食の次回からの摂取量を決めることができる。また、動物がケトン食をケトン体源として有効に代謝できる体調や体質か否かを判断することができる。そして、継続的に記録を取ることによって、動物の体調や体質の変化を把握することもできる。   According to the monitoring device 1 having the above-described configuration, it is possible to determine the intake from the next time of the ketone diet based on the determination result. In addition, it can be determined whether or not an animal can effectively metabolize ketone diet as a ketone body source. And, by recording continuously, it is possible to grasp changes in the physical condition and constitution of the animal.

モニタリング装置1によれば、ケトン食の摂取が有効な疾患の病者及び/又は病者予備軍者を対象として、食事中の糖質と脂質のバランスを調整するなどの食事の管理ができるケトン食は、その嗜好性から、好みにより、多量に摂取することが困難な場合があるが、モニタリング装置1によってモニタリングしながら摂取を調整できるので、必要十分量としての適度な量のみを摂食することができ、好みでないケトン食を過剰に摂取することを避けることができる。モニタリング装置1によれば、体調の維持や改善に有効なケトン食の摂食量が明確になる。したがって、摂食する動物(特にヒト)が、意識的或いは無意識的に摂食できる効果も併せ持つ。   According to the monitoring device 1, it is possible to control the diet such as adjusting the balance of carbohydrates and lipids in the diet for the sick and / or spare sick for the disease for which the intake of the ketone diet is effective Although it may be difficult to ingest a large amount of food depending on preference because of its palatability, it is possible to adjust the intake while monitoring with the monitoring device 1 and therefore only a proper amount as a necessary and sufficient amount is consumed. It is possible to avoid excessive intake of non-preferred ketone diets. According to the monitoring device 1, the amount of intake of ketone food effective for maintenance and improvement of physical condition is clarified. Therefore, the feeding animals (especially humans) also have the effect of consciously or unconsciously feeding.

モニタリング装置1は、測定結果の判定を表示する判定部32と、判定を表示する判定表示部22aを直接に接続して一箇所でモニタリングする装置であっても良いし、上記測定部21と判定表示部22aを含むモニタリング端末装置2と、データを扱うデータ取得部31とケトン食の有効状態を判定する判定部32とを有するモニタリング管理装置3とを、通信回路4を通じて接続したモニタリング装置1(図1)であっても良い。通信回路4は、電波、種々の公知の無線通信回線や有線通信回線などがあげられる。モニタリングは、リアルタイムであっても良いし、一定の時間差があっても良い。また、モニタリングは、一箇所で行われても良いし、複数の箇所、例えば、病者本人、医師、看護師、検査技師、栄養士、管理施設、ケトン食製造者など、であっても良い。   The monitoring device 1 may be a device in which the determination unit 32 for displaying the determination of the measurement result and the determination display unit 22a for displaying the determination are directly connected and monitored at one place, or may be determined as the measurement unit 21 The monitoring device 1 (the monitoring management device 3 having the monitoring terminal device 2 including the display portion 22a, the data acquisition portion 31 for handling data, and the determination portion 32 for determining the effective state of ketone corrosion) through the communication circuit 4 It may be as shown in FIG. Examples of the communication circuit 4 include radio waves, various known wireless communication circuits, and wired communication circuits. The monitoring may be real time or may have a fixed time difference. Moreover, monitoring may be performed at one place, or may be multiple places, for example, a sick person, a doctor, a nurse, a laboratory technician, a dietitian, a management facility, a ketone food manufacturer, and the like.

また、測定部と判定表示部と判断を受信して表示する判断表示部を含むモニタリング端末装置とデータ取得部と判定部、その判定を蓄積する判定蓄積部と蓄積された判定から判断する判定判断部を含むモニタリング管理装置(図2)とで構成されても良い。   In addition, a monitoring terminal device including a measurement display unit that receives and displays the measurement unit and the determination display unit and a determination unit, a data acquisition unit and a determination unit, a determination storage unit that stores the determination, and a determination determination determined from the accumulated determination It may be comprised with the monitoring management apparatus (FIG. 2) containing a part.

モニタリング端末装置は、腕時計やメガネと同形であっても良いし、アクセサリーやベルトなどの身に着けやすい、いかなる形であっても良い。さらに、複数のモニタリング端末装置を連動して管理するモニタリング管理サーバーを有しても良い。モニタリング管理サーバーでは、例えば、複数の患者の治療成績から、一般に最適な治療量を決めるために用いても良い。   The monitoring terminal may have the same shape as a watch or glasses, or any shape that is easy to wear such as accessories and belts. Furthermore, it may have a monitoring management server that manages a plurality of monitoring terminal devices in conjunction. The monitoring management server may generally be used to determine the optimal treatment amount, for example, from the treatment results of multiple patients.

モニタリング端末装置やモニタリング管理装置として、パーソナルコンピュータ、スーパーコンピュータなどを含めたいかなるディジタルコンピュータを用いてよいし、携帯電話、スマートフォン、タブレット、警報装置などを用いても良い。   As a monitoring terminal device or a monitoring management device, any digital computer including a personal computer, a super computer and the like may be used, or a mobile phone, a smartphone, a tablet, an alarm device or the like may be used.

図3は、本実施形態に係わるモニタリング装置の全体構成を示す機能ブロック図である。   FIG. 3 is a functional block diagram showing the entire configuration of the monitoring device according to the present embodiment.

モニタリング端末装置2は、アセトン濃度を測定するアセトン濃度測定部と判定等送信部からのデータを表示する表示部からなり、表示部には、判定表示部を含む。また、判定等送信部からのデータを表示する判断表示部を有しても良い。さらに、ケトン食の有効状態管理に有用な、その他の測定部を1つや複数含んでも良い。   The monitoring terminal device 2 includes an acetone concentration measurement unit that measures the acetone concentration and a display unit that displays data from the determination and transmission unit, and the display unit includes a determination display unit. In addition, it may have a judgment display unit for displaying data from the judgment etc. transmission unit. Furthermore, one or more other measuring units useful for managing the effective state of the ketone food may be included.

モニタリング管理装置3は、測定データを取得するデータ取得部、測定データを記録する記録部、データから代謝されたケトン体源食の量を判定する判定部からなる。また、判定を蓄積しておく判定蓄積部、蓄積した判定から食事の摂食量や脂肪量の調整、ケトン食の適応の可否をスクリーニングや判断する判定判断部を有しても良い。判定部からの判定と判定判断部からの判断は、判定等送信部を経由して判定表示部や判断表示部に送られてモニタリング端末装置に表示される。モニタリング管理装置には、データ記録部を含んでも良い。   The monitoring management device 3 includes a data acquisition unit that acquires measurement data, a recording unit that records measurement data, and a determination unit that determines the amount of ketone body source food metabolized from the data. Further, it may have a determination storage unit for storing determinations, and a determination and determination unit for adjusting the amount of food intake and fat amount based on the stored determinations and screening and determining the suitability of the ketone diet. The determination from the determination unit and the determination from the determination unit are sent to the determination display unit or the determination display unit via the determination transmission unit and displayed on the monitoring terminal device. The monitoring management device may include a data recording unit.

図4は、本実施形態に係わるモニタリング装置の構成を示す機能ブロック図である。   FIG. 4 is a functional block diagram showing the configuration of the monitoring device according to the present embodiment.

モニタリング装置1は、モニタリング端末装置2A〜2Cと、モニタリング管理装置3A〜3Cと、これらをつなぐ通信回路4A〜4Cとを有する。複数のモニタリング端末装置を有しても良く、複数のモニタリング端末装置を管理する1つ及び/又は複数のモニタリング管理装置を有しても良く、さらに、モニタリング管理装置を上位に管理するためのモニタリング管理サーバーを有しても良い。   The monitoring device 1 includes monitoring terminal devices 2A to 2C, monitoring management devices 3A to 3C, and communication circuits 4A to 4C connecting them. It may have a plurality of monitoring terminal devices, may have one and / or a plurality of monitoring management devices that manage a plurality of monitoring terminal devices, and further monitoring for managing a monitoring management device as a higher rank It may have a management server.

本発明は、本発明のモニタリング装置を使用した方法や使用方法、ケトン食の評価方法、ケトン食摂取量の管理方法、ケトン食摂食が有効な動物のスクリーニングなど、本発明のモニタリング装置を使用した一切のものを包含し、あらゆるものに応用できる。   The present invention uses the monitoring device of the present invention, such as a method and a method of using the monitoring device of the present invention, a method of evaluating a ketone diet, a method of managing a ketone diet intake, screening of animals effective for ketone feeding. It can be applied to all things, including all things done.

以上、本発明の実施形態について詳述したが、本発明は、前記の実施形態に限定されるものではなく、特許請求の範囲に記載された本発明の精神を逸脱しない範囲で、種々の設計変更を行うことができるものである。   As mentioned above, although the embodiment of the present invention was explained in full detail, the present invention is not limited to the above-mentioned embodiment, and various designs are possible in the range which does not deviate from the spirit of the present invention described in the claim. It is possible to make changes.

1 モニタリング装置
2 モニタリング端末装置
2A モニタリング端末装置A
2B モニタリング端末装置B
2C モニタリング端末装置C
3 モニタリング管理装置
3A モニタリング管理装置A
3B モニタリング管理装置B
3C モニタリング管理装置C
4 通信回路
4A 通信回路A
4B 通信回路B
4C 通信回路C
5 モニタリング管理サーバー
1 Monitoring Device 2 Monitoring Terminal Device 2A Monitoring Terminal Device A
2B Monitoring terminal B
2C Monitoring terminal C
3 Monitoring Management Device 3A Monitoring Management Device A
3B Monitoring management device B
3C Monitoring management device C
4 Communication circuit 4A Communication circuit A
4B Communication circuit B
4C Communication circuit C
5 Monitoring management server

Claims (7)

動物体内から体外に出される気体中のアセトン量を、ケトン食の有効状態を管理するために1回及び/又は複数回測定する、モニタリング装置。   The monitoring device which measures the amount of acetone in the gas taken out of the animal from the body once and / or multiple times to control the effective state of the ketone diet. 請求項1記載の動物がケトン食の摂取が有効な疾患の病者及び/又は病者予備軍者である、ケトン食の有効状態を管理するために1回及び/又は複数回測定する、モニタリング装置。   The animal according to claim 1 is a sick person and / or a sick person who is a sick person who is effective in taking a ketone diet, monitoring is performed once and / or a plurality of times to control an effective state of the ketone food apparatus. 請求項1記載のケトン食の有効状態の管理を、ケトン食の摂取前後の動物体内での代謝に併せてケトン食の摂取を管理するために1回及び/又は複数回測定する、モニタリング装置。   A monitoring device, wherein the management of the effective state of the ketone diet according to claim 1 is measured once and / or a plurality of times in order to control the intake of the ketone diet together with the metabolism in the animal before and after the intake of the ketone diet. 請求項1記載のケトン食の有効状態の管理を、ケトン食の有効状態の維持・改善に対する対象者の適性をスクリーニングするために1回及び/又は複数回測定する、モニタリング装置。   The monitoring apparatus which measures management of the effective state of the ketone diet of Claim 1 once and / or multiple times in order to screen a subject's aptitude for maintenance and improvement of the effective state of a ketone diet. ケトン食の有効性をモニタリングするケトン食モニタリング装置であって、
動物の体内に摂取されるケトン食の摂取量の情報を取得する摂取情報取得部と、
前記動物の体内から体外に出される気体中のアセトン量であるアセトン濃度を測定するアセトン濃度測定部と、
前記摂取情報取得部により取得した前記ケトン食の摂取量の情報と、前記アセトン濃度測定部により測定された前記アセトン濃度の情報とに基づいて前記動物による前記ケトン食の代謝状態を判定する判定部と、
を有することを特徴とするケトン食モニタリング装置。
A ketone diet monitoring device for monitoring the effectiveness of a ketone diet, comprising:
An intake information acquisition unit for acquiring information on the intake amount of ketone food to be ingested into the body of the animal;
An acetone concentration measuring unit which measures an acetone concentration which is an amount of acetone in a gas which is taken out from the body of the animal;
A determination unit that determines the metabolic state of the ketone diet by the animal based on the information on the intake amount of the ketone diet acquired by the intake information acquisition unit and the information on the acetone concentration measured by the acetone concentration measurement unit When,
The ketone food monitoring device characterized by having.
前記判定部は、前記ケトン食の摂取前後での前記アセトン濃度の増減に基づいて前記判定を行うことを特徴とする請求項5に記載のケトン食モニタリング装置。   The ketone diet monitoring apparatus according to claim 5, wherein the determination unit performs the determination based on increase and decrease of the acetone concentration before and after intake of the ketone diet. 前記判定部は、前記ケトン食の摂取前と比較して前記アセトン濃度が増加傾向を示す場合に、前記動物が前記ケトン食をケトン体源として代謝している状態、あるいは、前記動物が前記ケトン食をケトン体源として代謝可能な体調又は体質であると判定することを特徴とする請求項6に記載のケトン食モニタリング装置。   The determination unit is a state in which the animal is metabolizing the ketone diet as a ketone body source, or the animal is the ketone when the acetone concentration tends to increase as compared to before intake of the ketone diet. The ketone diet monitoring apparatus according to claim 6, wherein the food is determined to be a metabolizable condition or constitution capable of being metabolized as a ketone body source.
JP2017162775A 2017-04-06 2017-08-25 How to manage ketogenic diet intake Active JP6968624B2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
TW107111853A TWI816666B (en) 2017-04-06 2018-04-03 Monitoring device for the effectiveness of the ketogenic diet and management method for the ketogenic diet intake
US16/494,864 US11249087B2 (en) 2017-04-06 2018-04-06 Device for monitoring effective state of ketogenic diet
CN201880023394.9A CN110506211A (en) 2017-04-06 2018-04-06 For monitoring the device of the effective status of high fat diet
PCT/JP2018/014673 WO2018186481A1 (en) 2017-04-06 2018-04-06 Device for monitoring ketogenic diet efficacy

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017076201 2017-04-06
JP2017076201 2017-04-06

Publications (3)

Publication Number Publication Date
JP2018179960A true JP2018179960A (en) 2018-11-15
JP2018179960A5 JP2018179960A5 (en) 2020-09-24
JP6968624B2 JP6968624B2 (en) 2021-11-17

Family

ID=64275121

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017162775A Active JP6968624B2 (en) 2017-04-06 2017-08-25 How to manage ketogenic diet intake

Country Status (3)

Country Link
JP (1) JP6968624B2 (en)
CN (1) CN110506211A (en)
TW (1) TWI816666B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020016651A (en) * 2018-07-17 2020-01-30 大阪瓦斯株式会社 Index value determination system, mitochondrial activity evaluation system, index value determination method, and mitochondrial activity evaluation method
WO2020066839A1 (en) 2018-09-26 2020-04-02 パナソニックIpマネジメント株式会社 Warm-color complex phosphor, wavelength conversion body, and light emitting device
WO2021140640A1 (en) * 2020-01-10 2021-07-15 大阪瓦斯株式会社 Index value determination system, mitochondrial activiy evaluation system, index value determination method, and mitochondrial activity evaluation method

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2020255743A1 (en) * 2019-06-18 2020-12-24

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003079601A (en) * 2001-09-11 2003-03-18 Tanita Corp Measuring system of ketone body concentration in blood
US20160078782A1 (en) * 2014-09-17 2016-03-17 The Trustees Of Boston College Glucose Ketone Index for MetabolicTherapy
JP2016514725A (en) * 2013-03-19 2016-05-23 ユニヴァーシティ オブ サウス フロリダ Compositions and methods for producing enhanced and sustained ketosis
WO2017038101A1 (en) * 2015-09-04 2017-03-09 国立大学法人大阪大学 Development of dietary therapy in cancer
US20170332951A1 (en) * 2016-05-18 2017-11-23 Invoy Technologies, Llc Ketone measurement system for monitoring medical conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9183757B2 (en) * 2011-09-14 2015-11-10 Ntt Docomo, Inc. Dieting support system and dieting support method
CN103268414A (en) * 2013-05-20 2013-08-28 吉林市同益科技开发有限公司 Phenylketonuria managing method and system
JP2015141458A (en) * 2014-01-27 2015-08-03 株式会社タニタ diet support device, method, and program
CN107111855A (en) * 2015-01-07 2017-08-29 株式会社Ntt都科摩 Information processor, calorie management system, calorie revenue and expenditure method of estimation and program
CN105241828A (en) * 2015-08-19 2016-01-13 苏州华和呼吸气体分析研究所有限公司 CRDS acetone breath analyzer for noninvasively measuring blood ketone body level
CN106338597A (en) * 2016-10-18 2017-01-18 哈尔滨工业大学深圳研究生院 Respiratory gas measuring method and system

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003079601A (en) * 2001-09-11 2003-03-18 Tanita Corp Measuring system of ketone body concentration in blood
JP2016514725A (en) * 2013-03-19 2016-05-23 ユニヴァーシティ オブ サウス フロリダ Compositions and methods for producing enhanced and sustained ketosis
US20160078782A1 (en) * 2014-09-17 2016-03-17 The Trustees Of Boston College Glucose Ketone Index for MetabolicTherapy
WO2017038101A1 (en) * 2015-09-04 2017-03-09 国立大学法人大阪大学 Development of dietary therapy in cancer
US20170332951A1 (en) * 2016-05-18 2017-11-23 Invoy Technologies, Llc Ketone measurement system for monitoring medical conditions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NERI, GIOVANNI ET AL.: "Design and Development of a Breath Acetone MOS Sensor for Ketogenic Diets Control", IEEE SENSORS JOURNAL, vol. 10, no. 1, JPN6018025314, 2010, pages 131 - 136, XP055559818, ISSN: 0004524270, DOI: 10.1109/JSEN.2009.2035663 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020016651A (en) * 2018-07-17 2020-01-30 大阪瓦斯株式会社 Index value determination system, mitochondrial activity evaluation system, index value determination method, and mitochondrial activity evaluation method
JP7361517B2 (en) 2018-07-17 2023-10-16 大阪瓦斯株式会社 Index value determination system, mitochondrial activity evaluation system, index value determination method, and mitochondrial activity evaluation method
WO2020066839A1 (en) 2018-09-26 2020-04-02 パナソニックIpマネジメント株式会社 Warm-color complex phosphor, wavelength conversion body, and light emitting device
WO2021140640A1 (en) * 2020-01-10 2021-07-15 大阪瓦斯株式会社 Index value determination system, mitochondrial activiy evaluation system, index value determination method, and mitochondrial activity evaluation method

Also Published As

Publication number Publication date
TWI816666B (en) 2023-10-01
CN110506211A (en) 2019-11-26
JP6968624B2 (en) 2021-11-17
TW201842316A (en) 2018-12-01

Similar Documents

Publication Publication Date Title
Schwarzfischer et al. Physical activity and sedentary behavior from 6 to 11 years
Vinter et al. The LiP (Lifestyle in Pregnancy) study: a randomized controlled trial of lifestyle intervention in 360 obese pregnant women
JP2018179960A (en) Device for monitoring effective state of ketogenic meal
Lyons et al. Early life stress and inherited variation in monkey hippocampal volumes
Yam et al. Validity, practical utility and reliability of Actigraph accelerometry for the measurement of habitual physical activity in dogs
Guyer et al. Cycled light exposure reduces fussing and crying in very preterm infants
Wormald et al. Reduced heart rate variability in pet dogs affected by anxiety-related behaviour problems
Kahraman et al. The effects of auditory interventions on pain and comfort in premature newborns in the neonatal intensive care unit; a randomised controlled trial
Rodriguez-Hernandez et al. The effect of 2 walking programs on aerobic fitness, body composition, and physical activity in sedentary office employees
Best et al. Language exposure of preterm infants in the neonatal unit: a systematic review
Westerståhl et al. Association between nocturnal blood pressure dipping and insulin metabolism in obese adolescents
Dubuc et al. Who cares? Experimental attention biases provide new insights into a mammalian sexual signal
Wirth et al. Effects of standardized acoustic stimulation in premature infants: a randomized controlled trial
Terada et al. Test–retest reliability of a continuous glucose monitoring system in individuals with type 2 diabetes
Shepherd et al. When does prone sleeping improve cardiorespiratory status in preterm infants in the NICU?
Schmitz et al. Repeated anaesthesia with isoflurane and medetomidine-midazolam-fentanyl in guinea pigs and its influence on physiological parameters
Yoshida et al. Transport Response is a filial-specific behavioral response to maternal carrying in C57BL/6 mice
Idris et al. Relationship between chewing features and body mass index in young adolescents
Scherrenberg et al. The need for long-term personalized management of frail CVD patients by rehabilitation and telemonitoring: a framework
Burchert et al. Aerobic exercise training response in preterm-born young adults with elevated blood pressure and stage 1 hypertension: a randomized clinical trial
Timmermans et al. Towards Prepared mums (TOP-mums) for a healthy start, a lifestyle intervention for women with overweight and a child wish: study protocol for a randomised controlled trial in the Netherlands
WO2018186481A1 (en) Device for monitoring ketogenic diet efficacy
Mahnhardt et al. Anticipation and frequency of feeding affect heart reactions in domestic pigs
Lindsay Frazier et al. Obesity in pediatric oncology: assessment, treatment strategies, and knowledge gaps
Whelan et al. Brain activation in response to personalized behavioral and physiological feedback from self-monitoring technology: pilot study

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200807

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200807

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210608

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210729

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20211019

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20211027

R150 Certificate of patent or registration of utility model

Ref document number: 6968624

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150